Although the exact role of ANKRD18B in this process is still unclear, its significant alteration following Doxorubicin treatment, as shown in our study, suggests that it may be implicated in the response to therapy in HPV-positive cervical cancers. Here, ANKRD18B is linked to cervical carcinoma.